Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $21.81 USD
Change Today +0.69 / 3.27%
Volume 2.7M
HZNP On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey W. Sherman M.D., FACP

Chief Medical Officer and Executive Vice President of Research & Development, Horizon Pharma plc
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Jeffrey W. Sherman, M.D., F.A.C.P. has been Chief Medical Officer and Executive Vice President of Research and Development at Horizon Pharma plc since March 2010 and Horizon Pharma USA, Inc since June 2009 and September 2014 respectively. Dr. Sherman served as Executive Vice President of Development and Regulatory Affairs at Horizon Pharma plc since June 2009. Dr. Sherman served as Executive Vice President of Development, Regulatory Affairs, Manufacturing at Horizon ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, -- 4


Phone: 353 1 772 2100
Fax: --

Board Members Memberships*

President of Board of Directors


Rosalind Franklin University of Medicine and Science

Other Affiliations*

Annual Compensation*

Total Annual Compensation$396,340

Stock Options*

Restricted Stock Awards$231,914
All Other Compensation$600
Exercisable Options167,508
Exercisable Options Value$242,837
Unexercisable Options73,397
Unexercisable Options Value$281,337
Total Value of Options$524,174
Total Number of Options240,905

Total Compensation*

Total Annual Cash Compensation$595,112
Total Short Term Compensation$396,340
Other Long Term Compensation$232,514
Total Calculated Compensation$916,276
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HZNP:US $21.81 USD +0.69


Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HORIZON PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at